139 related articles for article (PubMed ID: 2429309)
1. Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.
Galizzi JP; Fosset M; Romey G; Laduron P; Lazdunski M
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7513-7. PubMed ID: 2429309
[TBL] [Abstract][Full Text] [Related]
2. Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade.
Qar J; Galizzi JP; Fosset M; Lazdunski M
Eur J Pharmacol; 1987 Sep; 141(2):261-8. PubMed ID: 2445589
[TBL] [Abstract][Full Text] [Related]
3. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes.
Galizzi JP; Fosset M; Lazdunski M
Biochem Biophys Res Commun; 1985 Oct; 132(1):49-55. PubMed ID: 2998366
[TBL] [Abstract][Full Text] [Related]
5. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
[TBL] [Abstract][Full Text] [Related]
6. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
7. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
Galizzi JP; Fosset M; Lazdunski M
Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
[TBL] [Abstract][Full Text] [Related]
8. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
Homaidan FR; Donowitz M; Weiland GA; Sharp GW
Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
[TBL] [Abstract][Full Text] [Related]
9. Selective antagonism of calcium channel activators by fluspirilene.
Kenny BA; Fraser S; Kilpatrick AT; Spedding M
Br J Pharmacol; 1990 Jun; 100(2):211-6. PubMed ID: 1696149
[TBL] [Abstract][Full Text] [Related]
10. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
[TBL] [Abstract][Full Text] [Related]
11. Identification and affinity labeling of very high affinity binding sites for the phenylalkylamine series of Ca+ channel blockers in the Drosophila nervous system.
Pauron D; Qar J; Barhanin J; Fournier D; Cuany A; Pralavorio M; Berge JB; Lazdunski M
Biochemistry; 1987 Oct; 26(20):6311-5. PubMed ID: 2827725
[TBL] [Abstract][Full Text] [Related]
12. The effect of the phenylalkylamine D888 (devapamil) on force and Ca2+ current in isolated frog skeletal muscle fibres.
Erdmann R; Lüttgau HC
J Physiol; 1989 Jun; 413():521-41. PubMed ID: 2557440
[TBL] [Abstract][Full Text] [Related]
13. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807
[TBL] [Abstract][Full Text] [Related]
14. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.
Gould RJ; Murphy KM; Reynolds IJ; Snyder SH
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5122-5. PubMed ID: 6136040
[TBL] [Abstract][Full Text] [Related]
15. Desmethoxyverapamil-sensitive calcium channels in rat portal vein smooth muscle.
Loirand G; Dacquet C; Pacaud P; Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
Eur J Pharmacol; 1989 Aug; 167(2):265-74. PubMed ID: 2556285
[TBL] [Abstract][Full Text] [Related]
16. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
Hagiwara M; Adachi-Akahane S; Nagao T
J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
[TBL] [Abstract][Full Text] [Related]
17. [3H] verapamil binding sites in skeletal muscle transverse tubule membranes.
Galizzi JP; Fosset M; Lazdunski M
Biochem Biophys Res Commun; 1984 Jan; 118(1):239-45. PubMed ID: 6696758
[TBL] [Abstract][Full Text] [Related]
18. The Ca2+ -antagonist and binding properties of the phenylalkylamine, anipamil.
Dillon JS; Nayler WG
Br J Pharmacol; 1988 May; 94(1):253-63. PubMed ID: 2456811
[TBL] [Abstract][Full Text] [Related]
19. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]